MAFA
EXAS

MJT & Associates Financial Advisory’s Exact Sciences EXAS Stock Holding History

MJT & Associates Financial Advisory’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-922
Closed -$93.6K – 454
2025
Q4 		$93.6K Hold
922
– – 0.07% 66
2025
Q3 		$50.4K Sell
922
-2,510
-73% -$125K 0.04% 80
2025
Q2 		$182K Hold
3,432
– – 0.23% 43
2025
Q1 		$149K Buy
+3,432
New +$174K 0.14% 60

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

MJT & Associates Financial Advisory's EXAS Position: Q1 2026 in Review

MJT & Associates Financial Advisory sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 922 shares — an estimated $93.6K sold.

MJT & Associates Financial Advisory first reported a position in EXAS in Q1 2025 and held it in 4 quarters. The position peaked at $182K in Q2 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • MJT & Associates Financial Advisory reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • MJT & Associates Financial Advisory sold 922 Exact Sciences shares in Q1 2026, an estimated $93.6K.
  • MJT & Associates Financial Advisory first reported a position in Exact Sciences in Q1 2025 and held it in 4 quarters.
  • MJT & Associates Financial Advisory's Exact Sciences position peaked at $182K in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q1 2026, filed 2 Apr 2026.